跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 46,409 条关于
“Syros Pharmaceuticals Inc.”
全部
46,409
临床试验
11,573
药物
3,158
机构
7,496
资讯
24,182
去年
Syros Pharmaceuticals Announces SELECT-MDS-1 Trial Update and Strategic Realignment
3年前
Syros Pharmaceuticals Advances Clinical Programs in MDS, AML, and APL
去年
Syros Pharma's Tamibarotene Fails in Phase III MDS Trial, Stock Plummets
去年
Syros' Tamibarotene Fails Phase III Trial in MDS Patients
去年
Quetzal Therapeutics Launches with $50 Million to Advance Oral Arsenic Trioxide Therapy for Acute Promyelocytic Leukemia
去年
Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals for ADPKD Development
去年
Syros' Tamibarotene Fails Phase III Trial in Higher-Risk Myelodysplastic Syndrome
去年
Syros' Tamibarotene Fails in Phase III Trial for Higher-Risk Myelodysplastic Syndrome
去年
Syros' Tamibarotene Fails in Phase III Trial for Higher-Risk Myelodysplastic Syndrome
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
第 1 页，共 2419 页
上一页
下一页
